» Articles » PMID: 20223596

Targets for Cancer Therapy in Childhood Sarcomas

Overview
Publisher Elsevier
Specialty Oncology
Date 2010 Mar 13
PMID 20223596
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Development of chemotherapeutic treatment modalities resulted in a dramatic increase in the survival of children with many types of cancer. Still, in case of some pediatric cancer entities including rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma, survival of patients remains dismal and novel treatment approaches are urgently needed. Therefore, based on the concept of targeted therapy, numerous potential targets for the treatment of these cancers have been evaluated pre-clinically or in some cases even clinically during the last decade. This review gives an overview over many different potential therapeutic targets for treatment of these childhood sarcomas, including receptor tyrosine kinases, intracellular signaling molecules, cell cycle and apoptosis regulators, proteasome, hsp90, histone deacetylases, angiogenesis regulators and sarcoma specific fusion proteins. The large number of potential therapeutic targets suggests that improved comparability of pre-clinical models might be necessary to prioritize the most effective ones for future clinical trials.

Citing Articles

Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients.

Zou C, Huang R, Lin T, Wang Y, Tu J, Zhang L Front Oncol. 2024; 14:1382276.

PMID: 38841159 PMC: 11150704. DOI: 10.3389/fonc.2024.1382276.


Bevacizumab, With Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory Osseous Sarcomas in Children and Young Adults.

Bodea J, Caldwell K, Federico S Front Oncol. 2022; 12:864790.

PMID: 35692751 PMC: 9174993. DOI: 10.3389/fonc.2022.864790.


Use of Antiangiogenic Therapies in Pediatric Solid Tumors.

Ollauri-Ibanez C, Astigarraga I Cancers (Basel). 2021; 13(2).

PMID: 33445470 PMC: 7827326. DOI: 10.3390/cancers13020253.


Dimethoate Induces DNA Damage and Mitochondrial Dysfunction Triggering Apoptosis in Rat Bone-Marrow and Peripheral Blood Cells.

Nazam N, Lone M, Hamid A, Qadah T, Banjar A, Alam Q Toxics. 2020; 8(4).

PMID: 33019668 PMC: 7712428. DOI: 10.3390/toxics8040080.


TBRG4 Knockdown Suppresses Proliferation and Growth of Human Osteosarcoma Cell Lines MG63 Through PI3K/Akt Pathway.

Huang F, Liao F, Ma G, Hu Y, Zhang C, Xu P Onco Targets Ther. 2020; 13:7271-7281.

PMID: 32801755 PMC: 7394601. DOI: 10.2147/OTT.S249477.